Search

01/10/2024 Impact of an emergency department nurse training intervention on the adequacy of thromboprophylaxis for venous thromboembolism: the PROTESU III study
Díaz, CR, Hernández, SJ, Chaib, FB, Polo, LL, Torrecillas, LG, Ayaso, MC, Abanto, AIC, García, JP, Gamito, GM, Jiménez, D, Lecumberri, R, Artacho, PR. Impact of an emergency department nurse training intervention on the adequacy of thromboprophylaxis for venous thromboembolism: the PROTESU III study. EMERGENCIAS. 2024; 36(5)DOI:10.55633/s3me/080.2024. PMID:39364989. IF:6.300(Q1/1D).
20/08/2024 Bjørn Ibsen: What Made Intensive Care So Critical?
Angeles-Sistac, D, Morán-Chorro, I, Morales-Quinteros, L. Bjørn Ibsen: What Made Intensive Care So Critical?. Cureus. 2024; 16(8)DOI:10.7759/cureus.67281. PMID:39301333. IF:(Q/D).
14/04/2024 Lance-Adams Syndrome in the Intensive Care Unit: A Case Report
Angeles-Sistac, D, Izura-Gomez, M, Barguilla-Arribas, A, Sierra-Marcos, A, Moran-Chorro, I. Lance-Adams Syndrome in the Intensive Care Unit: A Case Report. Cureus. 2024; 16(4)DOI:10.7759/cureus.58241. PMID:38745818. IF:(Q/D).
18/10/2024 Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support
Marín-Cerezuela, M, Martín-Latorre, R, Frasquet, J, Ruiz-Ramos, J, Garcia-Contreras, S, Gordón, M, Broch, MJ, Castellanos-Ortega, A, Ramirez, P. Cefiderocol pharmacokinetics in critically ill patients undergoing ECMO support. CRITICAL CARE. 2024; 28(1)DOI:10.1186/s13054-024-05126-4. PMID:39425201. IF:9.300(Q1/1D).
01/02/2024 Availability of antidotes in the primary care emergency centers of Catalonia
Salmerón, RA, Ametller, MAG, Albiach, AMJ, Sánchez, LM, Martínez, EFD, Cardús, ASI. Availability of antidotes in the primary care emergency centers of Catalonia. EMERGENCIAS. 2024; 36(1)DOI:10.55633/s3me/07.2023. PMID:38318746. IF:6.300(Q1/1D).
01/10/2025 Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation
Ramos-Rodríguez, J, Bonete-Sánchez, M, Ruiz-Ramos, J, Calderon-Hernanz, B, Campino-Villegas, A, de Lorenzo-Pinto, A, García-Peláez, M, García-Gutiérrez, MD, García-Martin, A, Real-Campaña, JM, Ginés-Palomares, A, Such-Díaz, A, Vallvé-Alcon, E, Alonso-Ramos, H. Impact on safety and cost of pharmaceutical interventions in the emergency department (INTERPHAR): a standardized methodology for multicenter documentation. EMERGENCIAS. 2025; 37(5)DOI:10.55633/s3me/082.2025. PMID:41185476. IF:6.300(Q1/1D).
01/05/2026 [Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning
Nogué-Xarau, S, Martínez-Sánchez, L, García-Peláez, M, de Gamarra-Martínez, EF, Pi-Sala, N, Gispert-Ametller, A, Salgado-García, E, Aguilar-Salmerón, R. [Translated article] N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning. Farmacia Hospitalaria. 2026; 50(3)DOI:10.1016/j.farma.2025.10.015. PMID:41318245. IF:(Q/D).
01/05/2026 N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning
Nogué-Xarau, S, Martínez-Sánchez, L, García-Peláez, M, de Gamarra-Martínez, EF, Pi-Sala, N, Gispert-Ametller, A, Salgado-García, E, Aguilar-Salmerón, R. N-acetylcysteine: 50 years since the discovery of an antidote that has changed the prognosis of acetaminophen poisoning. Farmacia Hospitalaria. 2026; 50(3)DOI:10.1016/j.farma.2025.07.005. PMID:40835518. IF:(Q/D).
01/04/2026 Clinical protocol for the use of biologic therapy in COPD
Rubio, MC, Soler-Cataluña, JJ, Campos, JLL, Navarrete, BA, González, FJC, Garin, N, Bernabéu-Morai, R, Rivasj, PC, Triguerosk, GE, Figueira-Gonçalves, JM, Gomila, AF, Mayoral, RG, Monge, GLA, Oto, MM, Martin, EM, de Miguel-Diez, J, Riesco, JA, Garcia, CR, Pérez, SS, Ecenarro, PS, Delgado, MS, Miravitlles, M. Clinical protocol for the use of biologic therapy in COPD. RESPIRATORY MEDICINE. 2026; 254DOI:10.1016/j.rmed.2026.108718. PMID:41722824. IF:3.100(Q2/4D).
01/03/2026 [Translated article] Guidelines on the perioperative management of chronic medication in surgical patients
Carbó, LVV, Gómez, MJE, Gómez, IRJ, Sánchez, AR, Oliveros, NV, Gil, ABG, Villegas, AC, Campillos, P, Martinez, PO, de Pourcq, JT. [Translated article] Guidelines on the perioperative management of chronic medication in surgical patients. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.11.002. PMID:41372088. IF:(Q/D).
01/03/2026 [Translated article] Risk stratification tool for pharmaceutical care in patients with cardiovascular disease
Lopez, AD, Escrig, EV, Serrano, PS, Morillo-Verdugo, R. [Translated article] Risk stratification tool for pharmaceutical care in patients with cardiovascular disease. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.11.001. PMID:41387041. IF:(Q/D).
01/03/2026 Guidelines on the perioperative management of chronic medication in surgical patients
Carbó, LVV, Gómez, MJE, Gómez, IRJ, Sánchez, AR, Oliveros, NV, Gil, ABG, Villegas, AC, Campillos, P, Martinez, PO, De Pourcq, JT. Guidelines on the perioperative management of chronic medication in surgical patients. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.07.002. PMID:40846569. IF:(Q/D).
01/03/2026 Risk stratification tool for pharmaceutical care in patients with cardiovascular disease
Lopez, AD, Escrig, EV, Serrano, PS, Morillo-Verdugo, R. Risk stratification tool for pharmaceutical care in patients with cardiovascular disease. Farmacia Hospitalaria. 2026; 50(2)DOI:10.1016/j.farma.2025.07.001. PMID:40877090. IF:(Q/D).
01/08/2021 Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel
Salvador, JFS, Gimenez-Arnau, AM, de la Fuente, EG, del Castillo, JG, Virto, AMM, Blanco, IM, Serra-Baldrich, E, Llorens, P. Managing urticaria in the emergency department: recommendations of a multidisciplinary expert panel. EMERGENCIAS. 2021; 33(4)DOI:. PMID:34251143. IF:5.345(Q1/2D).
01/10/2024 Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis
Augustin, M, Gottlieb, AB, Lebwohl, M, Pinter, A, Warren, RB, Puig, L, Warham, R, Lambert, J, Wiegratz, S, Szilagyi, B, Blauvelt, A. Complete Skin Clearance is Associated with the Greatest Benefits to Health-Related Quality of Life and Perceived Symptoms for Patients with Psoriasis. Dermatology and Therapy. 2024; 14(10)DOI:10.1007/s13555-024-01261-6. PMID:39285121. IF:4.200(Q1/1D).
01/01/2024 Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan
Tada, Y, Soliman, AM, Ishii, K, Sakuma, R, Puig, L, Davis, M, Nunag, D, Pinter, A, Imafuku, S. Real-World Discontinuation and Switching Patterns for Interleukin-Inhibitor Treatments in Patients with Moderate-to-Severe Psoriasis in Japan. Dermatology and Therapy. 2024; 14(1)DOI:10.1007/s13555-023-01064-1. PMID:38019410. IF:4.200(Q1/1D).
01/08/2024 Lymphatic Regeneration after Popliteal Lymph Node Excision and Implantation of Aligned Nanofibrillar Collagen Scaffolds: An Experimental Rabbit Model
Campos, J, Pons, G, Al-Sakkaf, AM, Lusetti, I, Pires, L, Vela, F, Ramos, E, Crisóstomo, V, Sánchez-Margallo, F, Abellán, E, Masiá, J. Lymphatic Regeneration after Popliteal Lymph Node Excision and Implantation of Aligned Nanofibrillar Collagen Scaffolds: An Experimental Rabbit Model. Journal of Functional Biomaterials. 2024; 15(8)DOI:10.3390/jfb15080235. PMID:39194673. IF:5.200(Q1/3D).
31/03/2024 Outcomes and considerations for retrograde intrarenal surgery (RIRS) in the setting of multiple and large renal stones (>15 mm) in children: Findings from multicentre and real-world setting
Juliebo-Jones, P, Gauhar, V, Lim, EJ, Traxer, O, Madarriaga, YQ, Castellani, D, Fong, KY, Bujons-Tur, A, Ragoori, D, Shretha, A, Vaddi, CM, Bhatia, TP, Sekerci, CA, Tanidir, Y, Teoh, JYC, Somani, BK. Outcomes and considerations for retrograde intrarenal surgery (RIRS) in the setting of multiple and large renal stones (>15 mm) in children: Findings from multicentre and real-world setting. Bjui Compass. 2024; 5(6)DOI:10.1002/bco2.357. PMID:38873356. IF:(Q/D).
01/06/2026 One year in: early European adoption of the da Vinci Single Port platform-a multi-institutional study from the European Association of Urology Robotic Urology Section Scientific Working Group
Pellegrino, F, Pellegrino, A, Falagario, UG, Tozzi, M, Weston, R, Hanchanale, V, Gandaglia, G, Briganti, A, Montorsi, F, Tuderti, G, Brassetti, A, Simone, G, Izzo, A, Spena, G, Contieri, R, Perdonà, S, Tedde, A, Madonia, M, Tappero, S, Mazzone, E, Dell'Oglio, P, Galfano, A, Decaestecker, K, Dekuyper, P, Ameye, F, Lavagno, F, Marra, G, Gontero, P, Costi, C, Passaretti, G, Russo, A, Gaboardi, F, Möller, A, Sundquist, F, Olsson, M, Vaccaro, C, Mistretta, FA, Luzzago, S, Musi, G, Piccolini, A, Paciotti, M, Lughezzani, G, Buffi, NM, Checcucci, E, Alessio, P, Amparore, D, Porpiglia, F, Marino, F, Di Gianfrancesco, L, De Marchi, D, Porreca, A, Fankhauser, C, Ferro, M, Breda, A, Crivellaro, S, Wiklund, P. One year in: early European adoption of the da Vinci Single Port platform-a multi-institutional study from the European Association of Urology Robotic Urology Section Scientific Working Group. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70193. PMID:41740983. IF:4.400(Q1/2D).
01/05/2026 Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups
Fernández-Mardomingo, A, Subiela, JD, Medina, AA, Krajewski, W, Pichler, R, van Creij, NCH, Lucena, MDDE, de la Parra, I, Ojeda, CM, Coloma, A, Martínez, LC, Durán, PD, González-Padilla, DA, Villacampa, F, Aumatell, J, Scilipoti, P, Longoni, M, Moschini, M, de Angelis, M, Caño-Velasco, J, Contieri, R, Gallioli, A, D'Andrea, D, Acosta, EA, Ajami, T, Grobet-Jeandin, E, Del Giudice, F, Santarelli, V, Slusarczyk, A, Albisinni, S, Soria, F, Mertens, LS, Tully, K, Mari, A, Guerrero-Ramos, F, Alvarez-Maestro, M, Melendres, FA, Buisan, O, Afferi, L, Gajate, P, Guerrero, P, Saiz, A, Pradere, B, Revilla, FJB. Impact of re-transurethral resection of bladder staging on risk stratification of high-grade T1 non-muscle-invasive bladder cancer across European Association of Urology 2021 risk groups. BJU INTERNATIONAL. 2026; 137(5)DOI:10.1111/bju.70207. PMID:41773726. IF:4.400(Q1/2D).
01/05/2026 Reply to Marcio Covas Moschovas, Mischa Dohler, Mohamad Omar Al Kalaa, and Vipul Patel's Letter to the Editor re: Bhaskar K. Somani, Jens Rassweiler, Evangelos Liatsikos, et al. European Association of Urology Policy on Telesurgery. Eur Urol 2025;88:318-24
Somani, BK, Rassweiler, J, Liatsikos, E, Mottrie, A, Knoll, T, Bedke, J, Bianchi, G, Sarica, K, Briganti, A, Brouwers, T, Breda, A. Reply to Marcio Covas Moschovas, Mischa Dohler, Mohamad Omar Al Kalaa, and Vipul Patel's Letter to the Editor re: Bhaskar K. Somani, Jens Rassweiler, Evangelos Liatsikos, et al. European Association of Urology Policy on Telesurgery. Eur Urol 2025;88:318-24. EUROPEAN UROLOGY. 2026; 89(5)DOI:10.1016/j.eururo.2025.11.012. PMID:41344928. IF:25.200(Q1/1D).
01/06/2026 Patient-side performance metrics and errors in robotic surgery: Junior- European Association of Urology Robotic Urology Section/Young Academic Urologists (J-ERUS/YAU) construct validation
Würnschimmel, C, Boese, M, Ognean, R, Paciotti, M, Wenzel, M, Bravi, CA, De Groote, R, Dell'Oglio, P, Di Maida, F, Moschovas, MC, Piramide, F, Turri, F, Sorce, G, Liakos, N, Gallagher, A, Veneziano, D, Brouwers, T, Graefen, M, Liatsikos, E, Breda, A, Larcher, A, Andras, I. Patient-side performance metrics and errors in robotic surgery: Junior- European Association of Urology Robotic Urology Section/Young Academic Urologists (J-ERUS/YAU) construct validation. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70199. PMID:41738369. IF:4.400(Q1/2D).
01/06/2026 The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working Group
Gallioli, A, Di Bello, F, Laukhtina, E, D'Andrea, D, Beltrami, P, Celso, FG, Krajewski, W, Afferi, L, Soria, F, Marcq, G, Del Giudice, F, De Lorenzis, E, Moschini, M, Mari, A, Subiela, JD, Baboudjian, M, Avesani, G, Territo, A, Basile, G, Dieguez, L, Izquierdo, P, Palou, J, Pradere, B, Breda, A. The Impact of II-look Ureteroscopy on Survival in Upper Tract Urothelial Carcinoma: A Multicenter Retrospective Study of EAU-YAU Urothelial Working Group. European Urology Open Science. 2026; 88DOI:10.1016/j.euros.2026.03.008. PMID:42088079. IF:4.500(Q1/2D).
01/06/2026 Curriculum-based training improves transurethral resection of bladder tumour performance compared to conventional training: the EuropeaN Training in uRologY (ENTRY) project
Diana, P, Di Bello, F, Mas, L, Gallioli, A, Paciotti, M, Frego, N, Mottrie, A, Palou, J, Buffi, N, Breda, A. Curriculum-based training improves transurethral resection of bladder tumour performance compared to conventional training: the EuropeaN Training in uRologY (ENTRY) project. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70223. PMID:41821175. IF:4.400(Q1/2D).
03/05/2026 Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer
Cella, L, Finocchiaro, A, Slusarczyk, A, Krajewski, W, Velasco, JC, Subiela, JD, Claps, F, Grobet-Jeandin, E, Del Giudice, F, Gallioli, A, Laukhtina, E, Marcq, G, Mari, A, Afferi, L, Albisinni, S, Soria, F, Hurle, R, Paciotti, M, Ferro, M, Perdonà, S, Mertens, LS, Moschini, M, Pradere, B, Contieri, R. Mitomycin for intravesical treatment of low-grade intermediate-risk non-muscle invasive bladder cancer. Future Oncology. 2026; 22(11)DOI:10.1080/14796694.2026.2661768. PMID:42041162. IF:2.600(Q3/6D).
01/05/2026 Confirmatory MRI and re-biopsy findings during active surveillance in patients with grade group 2 prostate cancer
Sanguedolce, F, Baboudjian, M, Rlos, AR, Leni, R, Oderda, M, Peyrottes, A, Kesch, C, Al-Nader, M, Uleri, A, Long-Depaquit, T, Dariane, C, Baud, H, Olivier, J, Benard, V, Windisch, O, Valerio, M, Gandaglia, G, Ploussard, G. Confirmatory MRI and re-biopsy findings during active surveillance in patients with grade group 2 prostate cancer. Actas Urologicas Espanolas. 2026; 50(4)DOI:10.1016/j.acuro.2025.501924. PMID:41587602. IF:1.200(Q3/7D).
01/06/2026 Refining BCG-failure classifications in non-muscle-invasive bladder cancer
Slusarczyk, A, Scilipoti, P, Contieri, R, Krajewski, W, Claps, F, Subiela, JD, Mertens, LS, Mori, K, Grobet-Jeandin, E, Velasco, JC, Tully, K, Soria, F, Duran, PD, Puentedura, AL, Lijnen, RAG, Longoni, M, Marcq, G, Mari, A, Laukhtina, E, Afferi, L, Albisinni, S, Gallioli, A, Del Giudice, F, Boorjian, SA, Briganti, A, Shariat, SF, Gontero, P, Radziszewski, P, Moschini, M, Pradere, B. Refining BCG-failure classifications in non-muscle-invasive bladder cancer. BJU INTERNATIONAL. 2026; 137(6)DOI:10.1111/bju.70231. PMID:41858138. IF:4.400(Q1/2D).
01/01/2022 Emergence of visual artistic creativity in frontotemporal dementia
Friedberg A., Pasquini L., Diggs R.T., Glaubitz E.A., Lopez L., Brown J.A., Rankin K.P., Allen I.E., La Joie R., Iaccarino L., Mundada N.S., Illán-Gala I., Bonham L.W., Yokoyama J.S., Miller Z.A., Rabinovici G.D., Kramer J.H., Rosen H.J., Tempini M.L.G., Seeley W.W., Miller B.L.. Emergence of visual artistic creativity in frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2022; 18DOI:10.1002/alz.065202. PMID:36537928. IF:(Q/D).
01/07/2025 High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia
Lisgaras, CP, Giménez, S, Carmona-Iragui, M, Maure-Blesa, L, Blessing, E, Fortea, J, Osorio, RS. High-frequency oscillations >250 Hz in people with Down syndrome and associated Alzheimer's disease dementia. ALZHEIMERS & DEMENTIA. 2025; 21(7)DOI:10.1002/alz.70386. PMID:40642994. IF:11.100(Q1/1D).
01/06/2025 Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome
Ledreux, A, Carmona-Iragui, M, Videla, L, Benejam, B, Barroeta, I, Lleó, A, Alcolea, D, Fortea, J. Cargo of small extracellular vesicles from neuronal origin shows progression of dementia in individuals with Down syndrome. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.70380. PMID:40524460. IF:11.100(Q1/1D).
01/06/2025 Diagnostic performance of plasma Aß42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study
Doecke, JD, Bellomo, G, Vermunt, L, Alcolea, D, Halbgebauer, S, In't Veld, S, Mattsson-Carlgren, N, Veverova, K, Fowler, CJ, Boonkamp, L, Houtkamp, IM, Koel-Simmerlink, M, Verberk, IMW, Gaetani, L, Toja, A, Wojdala, AL, Fortea, J, Pijnenburg, Y, Lemstra, A, van der Flier, W, Hort, J, Otto, M, Hansson, O, Parnetti, L, Masters, CL, Lleó, A, González-Escalante, A, Contador, J, Suárez-Calvet, M, Fernández-Lebrero, A, Puig-Pijoan, A, Ortiz-Romero, P, Jimenez-Moyano, E, Minguillón, C, del Campo, M, Teunissen, C. Diagnostic performance of plasma Aß42/40 ratio, p-tau181, GFAP, and NfL along the continuum of Alzheimer's disease and non-AD dementias: An international multi-center study. ALZHEIMERS & DEMENTIA. 2025; 21(6)DOI:10.1002/alz.14573. PMID:40551285. IF:11.100(Q1/1D).
01/04/2025 Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia
Memel, M, Staffaroni, AM, Ilan-Gala, I, Castro, JG, Kornak, J, Tartaglia, CM, Saloner, R, VandeBunte, AM, Paolillo, EW, Cadwallader, CJ, Chen, C, Gorno-Tempini, ML, Mandelli, M, Apostolova, L, Graff-Radford, N, Litvan, I, Bayram, E, Pressman, PS, Miyagawa, T, Mackenzie, I, Goldman, J, Darby, RR, Appleby, BS, Petrucelli, L, Gendron, T, Heuer, HW, Forseberg, LK, Rojas, JC, Boeve, BF, Brushaber, N, Domoto-Reilly, K, Ghoshal, N, Lapid, M, Pascual, B, Lee, S, Ramos, EM, Ramanan, V, Rademakers, R, Rascovsky, K, Pantelyat, A, Masdeu, JC, Snyder, A, Boxer, AL, Rosen, HJ, Casaletto, K. Sex differences in the clinical manifestation of autosomal dominant frontotemporal dementia. ALZHEIMERS & DEMENTIA. 2025; 21(4)DOI:10.1002/alz.14630. PMID:40277077. IF:11.100(Q1/1D).
15/01/2025 A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings
Mondésert, E, Schraen-Maschke, S, Quadrio, I, Bousiges, O, Bouvier, D, Delaby, C, Bedel, A, Lehmann, S, Fourier, A. A French multicenter analytical evaluation of the automated Lumipulse G sNfL blood assay (Fujirebio®) and its comparison to four other immunoassays for serum neurofilament light chain assessment in clinical settings. CLINICA CHIMICA ACTA. 2025; 565DOI:10.1016/j.cca.2024.120007. PMID:39454987. IF:2.900(Q1/1D).
01/01/2025 Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring
Petersen, ME, Flores-Aguilar, L, Head, E, Montoliu-Gaya, L, Strydom, A, Pape, SE, Fortea, J, Ashton, NJ, Udeh-Momoh, C, O'Bryant, SE, German, D, Despa, F, Mapstone, M, Zetterberg, H. Blood biomarkers in Down syndrome: Facilitating Alzheimer's disease detection and monitoring. ALZHEIMERS & DEMENTIA. 2025; 21(1)DOI:10.1002/alz.14364. PMID:39535517. IF:11.100(Q1/1D).
01/03/2024 Down Syndrome Biobank Consortium: A perspective
Aldecoa, I, Barroeta, I, Carroll, SL, Fortea, J, Gilmore, A, Ginsberg, SD, Guzman, SJ, Hamlett, ED, Head, E, Perez, SE, Potter, H, Molina-Porcel, L, Raha-Chowdhury, R, Wisniewski, T, Yong, WH, Zaman, S, Ghosh, S, Mufson, EJ, Granholm, AC. Down Syndrome Biobank Consortium: A perspective. ALZHEIMERS & DEMENTIA. 2024; 20(3)DOI:10.1002/alz.13692. PMID:38270275. IF:11.100(Q1/1D).
03/10/2025 Generational effects in Down syndrome: Enriched environment enhances functionality without reducing Alzheimer's disease risk
Vaque-Alcázar, L, Videla, L, Benejam, B, Soriano, LD, Barroeta, I, Fernandez, S, Rodriguez-Baz, I, Arriola-Infante, JE, Arranz, J, Blesa, LM, Sanjuan-Hernández, A, Morcillo-Nieto, AO, Bejanin, A, Arenaza-Urquijo, EM, Lleó, A, Bartres-Faz, D, Carmona-Iragui, M, Fortea, J. Generational effects in Down syndrome: Enriched environment enhances functionality without reducing Alzheimer's disease risk. ALZHEIMERS & DEMENTIA. 2025; 21(10)DOI:10.1002/alz.70447. PMID:41041908. IF:11.100(Q1/1D).
01/09/2025 Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum
Franquesa-Mullerat, M, Morcillo-Nieto, AO, Arriola-Infante, JE, Zsadanyi, SE, Vaqué-Alcázar, L, Rozalem-Aranha, M, Arranz, J, Rodríguez-Baz, I, Maure-Blesa, L, Videla, L, Barroeta, I, Soriano, LD, Benejam, B, Fernández, S, Hernandez, AS, Giménez, S, Alcolea, D, Belbin, O, Lleó, A, Carmona-Iragui, M, Fortea, J, Bejanin, A. Study of brain perfusion in adults with Down syndrome along the Alzheimer's disease continuum. ALZHEIMERS & DEMENTIA. 2025; 21(9)DOI:10.1002/alz.70581. PMID:40968330. IF:11.100(Q1/1D).
29/08/2024 Nutrition Users' Guides: RCTs Part 2-structured guide for interpreting and applying study results from randomised controlled trials on therapy or prevention questions
Bala, MM, Agarwal, A, Klatt, KC, Vernooij, RWM, Alonso-Coello, P, Steen, JP, Guyatt, GH, Duque, T, Johnston, BC. Nutrition Users' Guides: RCTs Part 2-structured guide for interpreting and applying study results from randomised controlled trials on therapy or prevention questions. Bmj Nutrition, Prevention & Health. 2024; DOI:10.1136/bmjnph-2023-000834. PMID:. IF:(Q/D).
01/04/2024 Social inequalities in the use of physiotherapy in women diagnosed with breast cancer in Barcelona: DAMA cohort
Cogollos-de-la-Peña, R, Alvarez-Vargas, A, Domínguez-Navarro, F, Espelt, A, Fuentes-Aparicio, L, Puigpinós-Riera, R. Social inequalities in the use of physiotherapy in women diagnosed with breast cancer in Barcelona: DAMA cohort. BREAST CANCER RESEARCH AND TREATMENT. 2024; 204(2)DOI:10.1007/s10549-023-07191-9. PMID:38155271. IF:3.000(Q2/5D).
01/04/2024 Executive summary of the consensus document on the management of perioperative anemia in Spain
Muñoz, M, Aragón, S, Ballesteros, M, Bisbe-Vives, E, Jericó, C, Llamas-Sillero, P, Meijide-Míguez, HM, Rayó-Martin, E, Rodríguez-Suárez, MJ. Executive summary of the consensus document on the management of perioperative anemia in Spain. REVISTA CLINICA ESPANOLA. 2024; 224(4)DOI:10.1016/j.rce.2024.02.001. PMID:38423382. IF:1.700(Q2/4D).
10/07/2021 Reductions in blood concentrations of persistent organic pollutants in the general population of Barcelona from 2006 to 2016
Porta, M, Pumarega, J, Henriquez-Hernandez, LA, Gasull, M, Bartoll, X, Arrebola, JP, Morales, E, Ibarluzea, J, Alguacil, J, Bilal, U, Luzardo, OP. Reductions in blood concentrations of persistent organic pollutants in the general population of Barcelona from 2006 to 2016. The Science of the total environment. 2021; 777DOI:10.1016/j.scitotenv.2021.146013. PMID:. IF:10.754(Q1/1D).
02/01/2026 Social and occupational aspects related to persistent low back pain in women geriatric nursing assistants
Campoy-Vila, M, Espelt, A, Borao, O, Artazcoz, L, Feliu-Soler, A, Jubany, J. Social and occupational aspects related to persistent low back pain in women geriatric nursing assistants. International Journal of Occupational Safety and Ergonomics. 2026; 32(1)DOI:10.1080/10803548.2025.2512658. PMID:40576141. IF:1.600(Q3/7D).
01/11/2024 Effectiveness of official food safety control in Barcelona city: Digital and traditional inspections
Grau-Noguer, E, Rodríguez-Sanz, M, Suppi, R, Serratosa, J, Lundén, J, Bolao, A, Cedano, D, Portaña, S. Effectiveness of official food safety control in Barcelona city: Digital and traditional inspections. FOOD CONTROL. 2024; 165DOI:10.1016/j.foodcont.2024.110655. PMID:. IF:6.300(Q1/2D).
01/06/2024 BeST-Graft viewer, a new system to improve the bone allograft-recipient matching process.
Vila M, Xiberta P, Ruiz M, Bermudo R, Leivas D, Fariñas O, Vilarrodona A, Boada I. BeST-Graft viewer, a new system to improve the bone allograft-recipient matching process.. COMPUTERS IN BIOLOGY AND MEDICINE. 2024; 176DOI:10.1016/j.compbiomed.2024.108553. PMID:38723397. IF:(Q/D).
01/02/2023 Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments - an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES)
Pascual-Izquierdo, C, Salmeron, PP, Ruiz, FT, Ferreiras, DV, Hernandez, SJ, Argente, RS, Galan, CD, Comos, JD. Immune thrombotic thrombocytopenic purpura: clinical suspicion and basic management in emergency departments - an expert review and consensus statement from the Spanish societies of hematology and hemotherapy (SEHH) and emergency medicine (SEMES). EMERGENCIAS. 2023; 35(1)DOI:. PMID:36756916. IF:5.400(Q1/1D).
01/12/2021 Characteristics of isolated superficial vein thrombosis and diagnostic-therapeutic management in Spanish hospital emergency departments: the ALTAMIRA study
Chaib, FB, Hernandez, SJ, Navas, JMP, Mancilla, JC, Arias, LC, Loranca, MM, Gomez, AP, Marquez, AA, Polo, LP, Garrido-Lestache, AS, Lecumberri, R, Artacho, PR. Characteristics of isolated superficial vein thrombosis and diagnostic-therapeutic management in Spanish hospital emergency departments: the ALTAMIRA study. EMERGENCIAS. 2021; 33(6)DOI:. PMID:34813190. IF:5.345(Q1/2D).
01/08/2024 Prophylaxis of venous thromboembolism in hospitalized patients admitted from Spanish emergency departments: the PROTESU II study
Díaz, CR, Hernández, SJ, Chaib, FB, Abanto, AIC, Ayaso, MC, Polo, LL, Torrecillas, LG, Valle, HA, Velilla, MO, Jiménez, D, Lecumberri, R, Artacho, PR. Prophylaxis of venous thromboembolism in hospitalized patients admitted from Spanish emergency departments: the PROTESU II study. EMERGENCIAS. 2024; 36(4)DOI:10.55633/s3me/051.2024. PMID:39234833. IF:6.300(Q1/1D).
01/01/2022 Características sociodemográficas, funcionales y consumo de recursos de la población mayor atendida en los servicios de urgencias españoles: una aproximación desde la cohorte EDEN
Miró Ò., Jacob J., García-Lamberechts E.J., Salmerón P.P., Llorens P., Jiménez S., Burillo-Putze G., Montero-Pérez F.J., Aguiló S., Gil-Rodrigo A., Alonso C.F., Alquézar-Arbé A., Parra-Esquivel P., Bayarri M.J.F., Tejera M.G., Soria J.M., Cirera I., Adroher M., Mojarro E.M., García E.G., Valle B., Salado Á.D., Grispán M.R., Díez M.P.L., Chaib F.B., Mota M.S., García J.P., Sindín G.S., González R.J., Pérez Costa R.A., Sánchez C.E., Zapico A.P., Del Castillo J.G.. Características sociodemográficas, funcionales y consumo de recursos de la población mayor atendida en los servicios de urgencias españoles: una aproximación desde la cohorte EDEN. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625691. IF:5.500(Q1/2D).
01/01/2022 El anciano frágil en urgencias: principales retos
Puig-Campmany M., Ris-Romeu J.. El anciano frágil en urgencias: principales retos. EMERGENCIAS. 2022; 34(6)DOI:. PMID:36625690. IF:5.500(Q1/2D).
01/01/2026 Current use and perspectives of PET imaging in Alzheimer's disease: A Spanish national survey
Cabrera-Martín, MN, Aguiar-Fernández, P, Camacho-Martí, V, Guillén-Valderrama, EF, Jiménez-Bonilla, JF, Lojo-Ramírez, JA, López-Mora, DA, Matías-Guiu, JA, Paredes-Rodríguez, P, Perissinotti, A, Arbizu, J. Current use and perspectives of PET imaging in Alzheimer's disease: A Spanish national survey. Journal Of Alzheimers Disease Reports. 2026; 10DOI:10.1177/25424823261437129. PMID:. IF:(Q/D).
01/03/2024 Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for = 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial
Puig L, Costanzo A, de Jong EMGJ, Torres T, Warren RB, Wapenaar R, Wegner S, Gorecki P, Gramiccia T, Jazra M, Buyze J, Conrad C. Guselkumab-Treated Patients with Plaque Psoriasis Who Achieved Complete Skin Clearance for = 156 Consecutive Weeks: A Post-Hoc Analysis From the VOYAGE 1 Clinical Trial. AMERICAN JOURNAL OF CLINICAL DERMATOLOGY. 2024; 25(2)DOI:10.1007/s40257-023-00816-1. PMID:37804472. IF:8.800(Q1/1D).
01/02/2024 Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA)
Reich, K, Bianchi, L, Khemis, A, Maul, JT, Tsianakas, A, Schempp, CM, Petersen, K, Noergaard, MM, Puig, L. Brodalumab Versus Guselkumab in Patients with Moderate-to-Severe Psoriasis with an Inadequate Response to Ustekinumab: A Randomized, Multicenter, Double-Blind Phase 4 Trial (COBRA). Dermatology and Therapy. 2024; 14(2)DOI:10.1007/s13555-023-01092-x. PMID:38300408. IF:4.200(Q1/1D).
01/07/2024 Experiences of Patients with Breast Cancer Participating in a Prehabilitation Program: A Qualitative Study
Casanovas-alvarez, A, Sebio-Garcia, R, Masià, J, Mateo-Aguilar, E. Experiences of Patients with Breast Cancer Participating in a Prehabilitation Program: A Qualitative Study. Journal of Clinical Medicine. 2024; 13(13)DOI:10.3390/jcm13133732. PMID:38999298. IF:2.900(Q1/2D).
01/04/2026 Reliable designs of breast sharing based on the internal mammary perforator flap for breast reconstruction
Rodriguez, C, Angrigiani, C, Pons, G, Van Landuyt, K, Masia, J. Reliable designs of breast sharing based on the internal mammary perforator flap for breast reconstruction. Journal of Plastic Reconstructive and Aesthetic Surgery. 2026; 115DOI:10.1016/j.bjps.2026.02.054. PMID:41861757. IF:2.400(Q1/3D).
01/04/2026 Propeller Modification of Tapia's Flap
Angrigiani, C, Masia, J, Peñaranda, A, Rancati, A, Felice, F, Dip, F, Rancati, A. Propeller Modification of Tapia's Flap. Aesthetic Surgery Journal. 2026; 46(4)DOI:10.1093/asj/sjaf216. PMID:41129682. IF:3.900(Q1/1D).
30/09/2024 Consensus statement addressing controversies and guidelines on pediatric urolithiasis (vol 42, 473, 2024)
Güven, S, Tokas, T, Tozsin, A, Haid, B, Lendvay, TS, Silay, S, Mohan, VC, Cansino, JR, Saulat, S, Straub, M, Tur, AB, Akguel, B, Samotyjek, J, Lusuardi, L, Ferretti, S, Cavdar, OF, Ortner, G, Sultan, S, Choong, S, Micali, S, Saltirov, I, Sezer, A, Netsch, C, de Lorenzis, E, Cakir, OO, Zeng, G, Gozen, AS, Bianchi, G, Jurkiewicz, B, Knoll, T, Rassweiler, J, Ahmed, K, Sarica, K. Consensus statement addressing controversies and guidelines on pediatric urolithiasis (vol 42, 473, 2024). WORLD JOURNAL OF UROLOGY. 2024; 42(1)DOI:10.1007/s00345-024-05282-w. PMID:39348069. IF:2.900(Q2/3D).
11/04/2026 Anatomical distribution and predictors of lymph node metastasis in robot-assisted radical nephroureterectomy for upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Robotic Surgery Working Group
Di Maida, F, Lambertini, L, Bravi, CA, De Groote, R, Piramide, F, Turri, F, Wenzel, M, Sharma, G, Würnschimmel, C, Lambert, E, Dell'Oglio, P, Moschovas, MC, Campi, R, Grosso, AA, Liakos, N, Mayr, R, Darlington, D, Eraky, A, Paciotti, M, Sorce, G, Tappero, S, Mottaran, A, Larcher, A, Montorsi, F, Briganti, A, Crisan, N, Mottrie, A, Minervini, A, Breda, A, Andras, I. Anatomical distribution and predictors of lymph node metastasis in robot-assisted radical nephroureterectomy for upper tract urothelial carcinoma: a multicenter study by the Junior ERUS/YAU Robotic Surgery Working Group. WORLD JOURNAL OF UROLOGY. 2026; 44(1)DOI:10.1007/s00345-026-06371-8. PMID:41964762. IF:2.900(Q2/3D).
01/03/2026 Long-term sexual function, fertility, and quality of life after childhood treatment for posterior urethral valves: a systematic review of clinical outcomes
Gnech, M, Pakkasjärvi, N, Hoen, L', Radmayr, C, Bogaert, G, Burgu, B, Castagnetti, M, Kennedy, U, O'Kelly, F, Quaedackers, J, Bujons, A, Van Uitert, A, Skott, M, Silay, MS, Zachou, A, Yuan, YH, Rawashdeh, YF. Long-term sexual function, fertility, and quality of life after childhood treatment for posterior urethral valves: a systematic review of clinical outcomes. Journal of Sexual Medicine. 2026; 23(3)DOI:10.1093/jsxmed/qdag035. PMID:41729776. IF:3.300(Q1/3D).
01/04/2026 Response to Commentary on "Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children"
Gnech, M, Bujons, A, Radmayr, C, Hoen, L, Bogaert, G, Burgu, B, Rawashdeh, YF, Silay, SM, O'Kelly, F, Quaedackers, J, Pakkasjärvi, N, van Uitert, A, Skott, M, Kennedy, U, Yuan, YH, Zachou, A, Castagnetti, M. Response to Commentary on "Update and summary of the EAU/ESPU paediatric guidelines on urinary tract infection in children". Journal of Pediatric Urology. 2026; 22(2)DOI:10.1016/j.jpurol.2025.08.041. PMID:41027790. IF:1.900(Q2/5D).
01/05/2026 Upper Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancer
Di Bello, F, Pradere, B, Laukhtina, E, D'Andrea, D, Del Giudice, F, Chung, BI, Krajewski, W, Zattoni, F, Soria, F, Afferi, L, Marcq, G, De Lorenzis, E, Moschini, M, Mari, A, Subiela, JD, Albisinni, S, Izquierdo, P, Dieguez, L, Avesani, G, Territo, A, Basile, G, Palou, J, Breda, A, Gallioli, A. Upper Endoscopic kidney-sparing surgery outcomes of high-grade upper tract urothelial cancer. UROLOGIC ONCOLOGY-SEMINARS AND ORIGINAL INVESTIGATIONS. 2026; 44(5)DOI:10.1016/j.urolonc.2026.111064. PMID:41876328. IF:2.300(Q2/5D).